Active, Not Recruiting
SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations
NCT06239480
- Conditions
- Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
- Locations
-
- Children's Hospital of Orange County Irvine, California, United States
- Stanford University Palo Alto, California, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- Minnesota Clinical Study Center New Brighton, Minnesota, United States